CRVS Market Cap & Key Metrics
Corvus Pharmaceuticals, Inc.
$10.62
-$0.85(-7.41%)
39
Overall
40
Value
40
Tech
39
Quality
Market Cap
$895.83M
Volume
1.02M
52W Range
$6.39 - $26.95
Target Price
$32.71
CRVS market cap is $895.83M. This page lists Corvus Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
CRVS Key Metrics
- Market cap
- $895.83M
- EPS estimate, current year
- $-0.79
- EPS growth, 3-year
- +40.23%
- Value score
- 40
- Quality score
- 39
- Technical score
- 40
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| EBITDA | -$42.87M | -$62.21M | -$26.88M | -$40.94M | -$38.17M |
| EPS | $-0.19 | $-1.02 | $-0.56 | $-0.89 | $-1.03 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRVS | $10.62 | -7.4% | 1.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corvus Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW